Harold E. Selick's most recent trade in Protagonist Therapeutics Inc was a trade of 24,000 Common Stock done at an average price of $12.9 . Disclosure was reported to the exchange on March 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.88 per share. | 26 Mar 2026 | 24,000 | 84,845 (0%) | 0% | 12.9 | 309,120 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 26 Mar 2026 | 24,000 | 60,845 (0%) | 0% | 105 | 2,520,000 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 26 Mar 2026 | 24,000 | 0 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.88 per share. | 26 Mar 2026 | 24,000 | 84,845 (0%) | 0% | 12.9 | 309,120 | - |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 26 Mar 2026 | 24,000 | 60,845 (0%) | 0% | 105 | 2,520,000 | - |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 09 Jan 2026 | 14,299 | 0 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.21 per share. | 09 Jan 2026 | 14,299 | 60,845 (0%) | 0% | 4.2 | 60,199 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.21 per share. | 09 Jan 2026 | 14,299 | 60,845 (0%) | 0% | 4.2 | 60,199 | - |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 02 Jan 2026 | 3,762 | 3,762 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 2,695 | 46,546 (0%) | 0% | 0 | Common Stock | |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 2,695 | 46,546 (0%) | 0% | 0 | - | |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 28 Apr 2025 | 10,725 | 0 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 28 Apr 2025 | 10,725 | 43,851 (0%) | 0% | 1.2 | 12,441 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 02 Jan 2025 | 6,584 | 6,584 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,130 | 33,126 (0%) | 0% | 0 | Common Stock | |
| Molecular Templates Inc | Harold E. Selick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 1,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 07 Mar 2024 | 6,490 | 0 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 07 Mar 2024 | 6,490 | 27,996 (0%) | 0% | 1.9 | 12,266 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 02 Jan 2024 | 25,700 | 25,700 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 10 Apr 2023 | 6,196 | 0 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.87 per share. | 10 Apr 2023 | 6,196 | 21,506 (0%) | 0% | 0.9 | 5,391 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 16 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | ||
| Molecular Templates Inc | Harold E. Selick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Dr. Harold E. Selick, PhD | Director | 26 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |